Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistanceIsha Kapoor, Alexandru Almasan|Cell Death and Disease|2020Cited by 257
Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignanciesIsha Kapoor, Alexandru Almasan|Cell Death and Disease|2019Cited by 76
Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiationIsha Kapoor, Arun Kumar Trivedi|Oncotarget|2015Cited by 19